Meet The Mount Sinai Mentors
Icahn School of Medicine at Mount Sinai
Jenny J. Lin, MD, MPH
Dr. Lin is a Professor of Medicine and the Director for Mentoring for the Department of Medicine at the Mount Sinai Health System in the Division of General Internal Medicine. She is also Associate Fellowship Director for the two T32 postdoctoral training programs that the Division holds. In addition, Dr. Lin is the Associate Director of the Medical Student Research Office for the Icahn School of Medicine at Mount Sinai and Associate Director of the Institutional Career Development Award (KL2 Program) for the Mount Sinai CTSA. Her research has focused on cancer survivorship, specifically regarding chronic disease management in cancer survivors. Professor Lin is currently PI on two projects assessing comorbidity management in cancer survivors: an NCI R01 assessing the impact of health beliefs and cognitive dysfunction on diabetes self-management behaviors in breast cancer survivors and an American Cancer Society study investigating the role of caregivers’ health beliefs on hypertension management in prostate cancer survivors. Dr. Lin has also recently begun another NCI R01 using simulation modeling to identify optimal lung cancer screening strategies for breast, prostate and colorectal cancer survivors.
BCPC Area: Cancer Prevention and Survivorship
Icahn School of Medicine at Mount Sinai
Deborah C. Marshall, MD
Dr. Marshall is an Assistant Professor in the Department of Radiation Oncology and in the Blavatnik Family Women’s Health Research Institute at the Icahn School of Medicine at Mount Sinai. She is also a member of the Cancer Prevention and Control Program of the Tisch Cancer Institute. Dr. Marshall is a physician with clinical expertise centered on treating young adults with cancer and those with breast, gastrointestinal and gynecologic cancers. She approaches each individual with the goal of maximizing the benefits of treatment while minimizing side effects using targeted approaches such as proton therapy and image-guided radiation therapy to create a highly customized radiation therapy plan. In addition to providing advanced radiotherapy to a diverse population of cancer patients, Dr. Marshall directs an NIH-funded laboratory aiming to advance the understanding of the impacts of radiotherapy on sexual function in women and LGBTQ+ cancer patients across the lifespan. F
Icahn School of Medicine at Mount Sinai
Sarah Miller, PsyD
Dr. Miller is a licensed clinical psychologist and an Assistant Professor in the Department of Population Health Science and Policy in the Center for Behavioral Oncology at the Icahn School of Medicine at Mount Sinai. She is also an Associate Member of the Tisch Cancer Institute. Dr. Miller's research interests lie in identifying physician and patient factors that contribute to low cancer screening rates and designing interventions to improve cancer prevention and treatment efforts, particularly among socioeconomically disadvantaged populations. Her most recent research has been focused on developing digital health interventions to reduce the burden of cancer among racial/ethnic minorities.
BCPC Area: Early Detection and Treatment/Symptom Management
Icahn School of Medicine at Mount Sinai
Guy Montgomery, PhD
Dr. Montgomery is a clinical psychologist whose research, training, and clinical efforts are focused on improving patients’ quality of life associated with cancer and its treatment. In particular, he is focused on developing and testing mind-body interventions to reduce the symptoms and side- effects associated with cancer and its treatment, such as including pain, nausea, and fatigue. His work recognizes that how people think (e.g., evaluation of situations, expectations about how one reacts to medical treatment), and how people feel emotionally (e.g., anxiety, distress) can have profound effects on how they feel physically. Dr. Montgomery has extensive experience in studying the contribution of cognitive factors (especially expectancies) to individuals’ experiences. His goal is to provide all cancer patients with the tools and skills they need to enhance their quality of life during the rigors of cancer treatment. From predictive studies of response expectancy effects, to intervention studies looking to exploit expectancy effects to improve patient quality of life, the role and impact of cognitions is a common theme throughout Dr. Montgomery's research.
Icahn School of Medicine at Mount Sinai
Minal S. Kale, MD
Dr. Kale is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai and practices primary care at Internal Medicine Associates in addition to conducting clinical research in lung cancer screening. She attended University of Cincinnati College of Medicine and completed Internal Medicine residency at New York University.
BCPC Area: Cancer Prevention, Early Detection and Treatment/Symptom Management
Icahn School of Medicine at Mount Sinai
Julie Schnur, PhD
Dr. Schnur is a licensed clinical psychologist, an Associate Professor in the Department of Population Health Science & Policy, a Member of Mount Sinai’s Center for Behavioral Oncology (CBO), and the Co-Director of the Integrative Behavioral Medicine Program within CBO. Her research activities focus on developing and testing psychosocial intervention to improve women’s quality of life during breast cancer care, conducting qualitative research to better understand individuals’ emotional and physical reactions to cancer and its treatment, and developing and implementing programs to train cancer care providers in evidence-based cancer care strategies. Dr. Schnur's current research focuses on training cancer care providers to work sensitively with individuals with a history of sexual violence.
Icahn School of Medicine at Mount Sinai
Jamilia Sly, PhD
Dr. Sly is a community psychologist and an Assistant Professor in the Department of Population Health Science and Policy in the Center for Behavioral Oncology at the Icahn School of Medicine at Mount Sinai. She is also an Associate Member of the Tisch Cancer Institute at Mount Sinai and served as the Chair of the Health Equity Special Interest Group for the Society of Behavioral Medicine. Dr. Sly's research is focused on developing clinical and community-based interventions to reduce and ultimately eliminate cancer disparities. She has nearly 10 years of experience collaborating with community-based organizations in New York City on research and educational outreach efforts. Dr. Sly has experience conducting quantitative and qualitative studies and has received NIH and ACS funding to examine: (1) the cultural adaptation of an evidence-based intervention to increase Latinos’ participation in colorectal cancer screening; (2) the capacity and variations among community and faith-based organizations for recruiting research participants for colorectal cancer prevention and health-related interventions; (3) the influence of social networks and social capital on cancer screening and health outcomes among minorities in public housing; and (4) the feasibility and acceptability of a community based breastfeeding educational program for black women.
BCPC Area: Early Detection
Icahn School of Medicine at Mount Sinai
Juan Wisnivesky, MD, DrPH
Dr. Wisnivesky is a health services researcher with a focus on lung cancer epidemiology and comparative effectiveness research. His prior work has been related to lung cancer treatment in the elderly and disparities in care. Dr. Wisnivesky has been involved in several projects involving SEER-Medicare data and other large cancer registries. He has served as the PI of three R01s to evaluate the staging and treatment of lung cancer using the SEER-Medicare registry and an ongoing R01 assessing the impact of lung cancer screening in HIV-infected individuals. He is also the PI of an R01 using a simulation model to optimize the management of lung cancer patients with comorbidities, and a second NCI-funded R01 evaluating the comparative effectiveness of SBRT vs. limited resection for early stage lung cancer. Additionally, Dr. Wisnivesky was the PI of a 4-site cohort study funded by the American Cancer Society to study disparities in lung cancer care. These experiences provided a strong foundation in the design, implementation, analyses of observational studies, and mathematical modeling.